BE Semiconductor Hit With Back-to-Back Downgrades Over AI Chip Bet

When two major banks pull the rug out from under the same stock within 24 hours, it's worth paying attention — especially when the stock in question has been one of the hottest AI chip-equipment names in Europe.

BE Semiconductor Industries (BESI), the Dutch chip-equipment maker, got hit with a sell rating from UBS and a downgrade to neutral from Bank of America this week. Shares fell as much as 6.4% on the news, adding to a brutal stretch that's seen the stock drop about 40% from its June peak.

UBS cut its rating to sell from buy and slashed its price target by 57%, from €370 to just €159. The firm's issue isn't with Besi's technology — it's with the timeline for adoption. UBS said expectations for hybrid bonding demand, the chip-packaging technique at the center of Besi's entire growth story, "were not stacking up."

Specifically, UBS now projects hybrid bonding will account for just 10% of tool demand by 2028, versus the roughly 50% the market has reportedly been pricing in. That's not a small miss — it implies Besi's 2027-2028 hybrid bonding revenue could land 50% to 60% below what analysts currently expect. UBS also argued that demand from co-packaged optics, AI accelerators and PC processors is unlikely to make up the shortfall, since existing installed capacity at TSMC and Intel can already support meaningful volumes without new orders.

"The threat that a company like ASML could enter Besi's key growth market... is not reflected in the stock and could remain an overhang." — Didier Scemama, Bank of America analyst

Bank of America's downgrade focused on a different but related risk: competition. ASML, the Dutch lithography giant, has publicly said it's looking at entering the hybrid bonding space — the same market Besi currently dominates, with Bernstein projecting the company will account for roughly three out of every four hybrid bonding tools shipped globally by 2028.

BofA's analysts, led by Didier Scemama, cut their rating to neutral and nearly halved their price target. Their argument: even if ASML doesn't grab significant market share right away, the mere threat of a heavyweight competitor entering the space injects uncertainty that the current stock price doesn't adequately reflect. ASML's CEO Christophe Fouquet said back in April that the company continues to "look at the opportunity to support our customers" in hybrid bonding — not a firm commitment, but enough to spook analysts already nervous about Besi's valuation.

Here's the tension for investors: Besi's technology is real, and the long-term bull case — AI accelerators needing more advanced chip-packaging as classic transistor scaling slows down — hasn't gone away. The stock is still up 45% year-to-date even after this pullback, which tells you how much froth built up before this correction started. Besi's own guidance points to shipping more than 2,000 hybrid bonding tools by 2030 in an optimistic scenario, with cumulative orders already above 150 as of its last annual report.

But two independent downgrades citing two different flavors of the same underlying risk — slower adoption timelines and new competitive threats — is a signal that the easy money on this name has probably already been made. Besi was already the worst-performing stock in the Stoxx 600 during the third quarter, and this week's moves suggest that trend isn't finished playing out.

If you're holding Besi, this isn't necessarily a sell-everything moment, but it's a reasonable time to trim the position down to something you're comfortable holding through more volatility. The stock could see further downside if ASML provides any concrete update on its hybrid bonding ambitions in the coming months.

If you don't already own it, there's no rush to catch this falling knife. Wait for either UBS's downside scenario to play out in the numbers, or a clearer signal from ASML about its actual plans, before stepping in. The bottom line: Besi's growth story isn't broken, but two Wall Street banks just told you the timeline got a lot murkier than the stock price has been assuming.